Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kirsty Moran"'
Autor:
Graeme Elliott, Joris Tinnemans, Tristan Rawlence, Doug P. Armstrong, Mara Nydegger Bell, Christopher Bell, Kirsty Moran, Anja McDonald
Publikováno v:
New Zealand Journal of Ecology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f4c8e7c150e2346357e62df70a4ddac
https://doi.org/10.20417/nzjecol.45.53
https://doi.org/10.20417/nzjecol.45.53
Autor:
Tristan Rawlence, Joris Tinnemans, Kirsty Moran, Christopher Bell, Mara Nydegger Bell, Anja McDonald, Graeme Elliott
Publikováno v:
New Zealand Journal of Ecology. 43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d9773759ed94d2f0eae33779586c43a
https://doi.org/10.20417/nzjecol.43.7
https://doi.org/10.20417/nzjecol.43.7
Autor:
Johann S. de Bono, Géraldine Perkins, Penelope Flohr, Sadiya Saeed, Stanley B. Kaye, Helen Nicole Toloui, Amy Mulick Cassidy, Anne Mary Young, Michael Ong, L Rhoda Molife, Michael A Gonzalez, Udai Banerji, Kirsty Moran, Joaquin Mateo, Khurum Khan, Matthew C.H. Ng, Ruth Riisnaes, Timothy A. Yap, Khin Thway, Lorna Pope
Publikováno v:
Journal of Clinical Oncology. 30:6-6
6 Background: Previous studies suggest that tumoral cfDNA is a potential biomarker in cancer. Methods: Prospective collection of samples from patients (pts) referred to a phase I trials unit, in 2 cohorts: “A”(manual isolation of cfDNA, Sep09-Dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::667bdef101cd161407d4369eab484b4c
https://doi.org/10.1200/jco.2012.30.30_suppl.6
https://doi.org/10.1200/jco.2012.30.30_suppl.6
Autor:
Kirsty Moran, Amy Mulick Cassidy, Stanley B. Kaye, Timothy A. Yap, Jen Kate Lewis, Ruth Riisnaes, Géraldine Perkins, Jesus Corral Jaime, Sadiya Saeed, Michael Ong, Helen Nicole Toloui, L Rhoda Molife, Khin Thway, Lorna Pope, Udai Banerji, Joaquin Mateo, K. A. Denholm, Andrea Biondo, Penelope Flohr, Johann S. de Bono
Publikováno v:
Journal of Clinical Oncology. 30:10525-10525
10525 Background: Studies suggest that tumoral cfDNA can be isolated from plasma and used as a biomarker. Methods: We conducted a prospective study in adult pts with advanced cancer referred for phase I clinical trials Sep09-Dec10 (A: Pilot Phase n=1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a221876a07a0c9f806c0e34badf146bf
https://doi.org/10.1200/jco.2012.30.15_suppl.10525
https://doi.org/10.1200/jco.2012.30.15_suppl.10525
Autor:
Martin Gutierrez, Axel Walther, Rod A. Humerickhouse, M. Puglisi, Montserrat Blanco, Jianning Yang, Maja J.A. de Jonge, David Cosgrove, Lulama Rhoda Molife, Catherine Franklin, Todd A. Busman, Mack Mabry, Ferry A.L.M. Eskens, Kirsty Moran, Leni van Doorn
Publikováno v:
Molecular Cancer Therapeutics. 10:A92-A92
Background: Navitoclax (N; ABT-263) is a first-in-class orally available Bcl-2 protein inhibitor that in vitro and in vivo potentiates docetaxel (D) activity across a variety of solid tumor types. This ongoing phase I study evaluates the maximum tole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1aa1ea29f00a51c6da169699683bbb21
https://doi.org/10.1158/1535-7163.targ-11-a92
https://doi.org/10.1158/1535-7163.targ-11-a92
Autor:
J.E. Ang, S.R.D. Johnston, James Spicer, Charles Swanton, Andrew Tutt, Bristi Basu, N. Dobbs, J.S. de Bono, S. Wan, Mitch Dowsett, Florence I. Raynaud, Montserrat Blanco-Codesido, Debashis Sarker, Elizabeth Folkerd, Danielle Crawley, Kirsty Moran
Publikováno v:
Journal of Clinical Oncology. 29:2525-2525
2525 Background: Many advanced ER+ breast cancer pts show intrinsic resistance to endocrine treatment with the remainder acquiring resistance. Androgenic steroids upstream of aromatase can drive st...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32bea3c36350245463491d1f93cee4a6
https://doi.org/10.1200/jco.2011.29.15_suppl.2525
https://doi.org/10.1200/jco.2011.29.15_suppl.2525
Autor:
Jianning Yang, L. van Doorn, M. Puglisi, F. Eskens, L. R. Molife, Rod A. Humerickhouse, Andrew Krivoshik, Todd A. Busman, Montserrat Blanco-Codesido, Mack Mabry, Catherine Franklin, Kirsty Moran, M.J.A. de Jonge
Publikováno v:
Journal of Clinical Oncology. 29:2518-2518
2518 Background: N (ABT-263) is a first-in-class orally available Bcl-2 protein inhibitor that in vitro and in vivo potentiates D activity across a variety of solid tumor types. This phase I study ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f78d126f19be902b47f68fd29d57bec
https://doi.org/10.1200/jco.2011.29.15_suppl.2518
https://doi.org/10.1200/jco.2011.29.15_suppl.2518
Autor:
Kemp, Joshua R.1 (AUTHOR) jkemp@doc.govt.nz, Young, Laura1,2 (AUTHOR), Mosen, Corey1,2 (AUTHOR), Bolitho, Liam1,2,3 (AUTHOR), Orr-Walker, Tamsin2 (AUTHOR), Yockney, Ivor4 (AUTHOR), Elliott, Graeme1 (AUTHOR)
Publikováno v:
New Zealand Journal of Zoology. Jun2023, Vol. 50 Issue 2, p279-304. 26p.
Autor:
Malham, Jason1, Elliott, Graeme1 gelliott@doc.govt.nz
Publikováno v:
New Zealand Journal of Ecology. 2023, Vol. 47 Issue 1, p1-17. 17p.
Publikováno v:
New Zealand Journal of Ecology. 2019, Vol. 43 Issue 2, p1-9. 9p.